Financial Shenanigans

Financial Shenanigans — Partners Group Holding AG (PGHN)

Figures converted from Swiss francs at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

Partners Group is an asset-light Swiss private-markets manager whose reported numbers are, on the whole, a faithful representation of economic reality — but the quality of those numbers turns almost entirely on two judgment areas: when lumpy, exit-dependent performance fees get recognized, and how the firm's internal Level-3 valuations of private assets feed both those fees and fair-value gains. The accounting is conservatively framed and well disclosed (a Key Audit Matter on revenue recognition appears in every year reviewed), there is no restatement, no regulator action, and no auditor resignation. What keeps this off a clean "0–20" grade is a cluster of linked, sector-normal-but-material yellow flags — timing-sensitive earnings, a thinly-reserved $2.09bn loan book, an EBIT→EBITDA headline-metric switch, founder/board concentration, and a live short-seller and evergreen-redemption overhang aimed squarely at the valuations the whole model depends on.

Forensic verdict

Source: derived from reported financials, FY2021–FY2025 annual reports — net income and total revenue [1] [2]; operating cash flow from the consolidated cash-flow statement [3].

Grade: 38 / 100 — Watch (upper end, bordering Elevated). The reported economics look real and cash-backed across the cycle; the risk is concentrated in disclosed judgment areas, not in evidence of distortion.

Top two concerns.

1. Valuation-dependence of earnings. Performance fees (32% of FY2025 revenue) and own-investment fair-value gains both rest on Partners Group's internal valuations of unlisted assets — the same valuations a short-seller (Grizzly Reports, April 2026) has publicly challenged and that evergreen-vehicle redemptions (flagged through mid-2026) put under live scrutiny [27]. If those marks are soft, both revenue lines are soft.
2. Lumpy, pre-cash performance-fee recognition. Performance fees have swung between 14% and 46% of revenue in five years and are booked on accrual before collection, building a large accrued-revenue receivable. Earnings quality is therefore timing-sensitive and management-discretionary on exit timing [15].

Cleanest offsetting evidence. In FY2025, operating cash flow of $1,911m exceeded net income of $1,590m (CFO/NI 1.20) as prior years' accrued performance fees converted to cash and the reporting-currency accrued-revenue receivable fell — the accrual reversed into cash, validating the earlier recognition rather than contradicting it [3] [5].

The one data point that would change the grade. Evidence that performance fees were recognized against valuations later marked down — i.e. clawbacks/reversals materializing, or evergreen NAVs cut — would move this to Elevated/High. Sustained cash conversion with no clawbacks confirms Watch and trends it toward Clean.

The 13-category shenanigans scorecard

The map below is the required cross-company forensic grid. Eight categories carry yellow flags; none are red. The earnings-quality and cash-flow concerns are linked — they trace back to the same root: performance fees recognized on internal valuations before cash arrives.

Source: severity assessments derived from FY2021–FY2025 annual reports and H1 2025 interim report — revenue-recognition Key Audit Matter [18]; short-term-loan loss allowance [14]; metric change [6].

Earnings quality: a recurring base, a lumpy overlay

The single most important earnings-quality fact about Partners Group is the split between recurring management fees — stable, AuM-linked, ~$2.2bn and growing every year — and performance fees, which are realization-driven and swing violently. Management fees rose steadily from $1,527m (FY2021) to $2,200m (FY2025) [2] [1]. Performance fees, by contrast, were $1,312m in FY2021 (a 46%-of-revenue catch-up spike), collapsed to $291m in FY2022, and climbed back to $1,033m (32%) by FY2025 [2] [1].

Source: FY2021–FY2025 annual reports, financial review — management and performance fees as reported [2] [1].

Source: FY2021 and FY2025 annual reports, financial review (FY2021 46%; FY2020 19%; FY2025 32%) [2] [1]; FY2024 24% [30]; FY2023 19% [15].

EM1 / EM3 — recognition timing and sustainability (yellow). Performance fees are recognized when management judges the probability of a future clawback or reversal to be very low — a judgment that the external auditor has flagged as a Key Audit Matter in every annual report reviewed, citing the manual interventions and portfolio-valuation dependence involved [18] [19]. The auditor's continued focus is reassuring (the area is scrutinized), but it confirms this is the firm's principal earnings-quality pressure point. The forensic implication is not that the numbers are wrong — it is that roughly a third of FY2025 revenue should not be capitalized into a steady-state multiple. A reader underwriting PGHN should anchor on the ~$2.2bn recurring management-fee base, not the headline.

EM6 — income smoothing through exit timing (yellow). Partners Group is unusually candid that it controls the timing of realizations. In FY2023 the firm explicitly "elected to postpone most exits originally" planned for the second half because the exit market was soft, skewing performance income across periods [15]. In H1 2025 it did the reverse — "bringing forward" performance-fee guidance originally set for 2026 into 2025 as exits accelerated, with performance fees up 94% half-on-half [16]. This is legitimate (exit timing genuinely is discretionary), but it means reported half-yearly and annual performance income is a managed signal, not a clean read on underlying value creation.

Income statement vs balance sheet: the accrued-revenue tell

The cleanest cross-statement test for a fee accrual model is whether recognized-but-uncollected revenue is building on the balance sheet. It was — and then it drew down. Total accrued revenue (current plus non-current) climbed from $784m (FY2021) to $1,337m (FY2024) through the low-exit years, then eased to $1,357m in FY2025 as exits realized and cash came in (the modest USD level reflects Swiss-franc appreciation; in reporting-currency terms the receivable fell) [5] [26]. The intra-year path confirms the mechanism: current accrued revenue actually peaked near $1,228m at H1 2025 before full-year collection drew it down to $947m [17].

Source: FY2025 balance sheet (non-current accrued revenue) and Note 3.1.1 (current accrued revenue); prior years from comparatives and FY2021/FY2024 annual reports [5] [26].

The FY2025 drawdown (in reporting-currency terms) is the most important single piece of confirming evidence in this memo: the receivable that performance-fee recognition created actually converted to cash, which is exactly what should happen if the recognition was sound. A receivable that only ever builds would be the red flag; this one cycles.

EM5 — under-reserving on the loan book (yellow). Partners Group lends short-term to its own managed programs (bridging, NAV and credit-facility loans). The book stood at $2,090m at end-FY2025, yet the expected-credit-loss allowance against it was just $2.0m — about 0.1% — and the allowance on fee receivables and accrued revenue was deemed "immaterial," so none was booked [5] [14]. The counterparties are the firm's own funds, so historical losses are genuinely near-zero — but a near-nil reserve on a $2.09bn book is an area where a private-markets downturn would show up first, and the cushion is thin by construction.

EM7 — no big-bath behavior (green). No goodwill or intangible impairment was recognized in any year from FY2021 through FY2025, and there were no restructuring baths or one-time write-offs [13]. That clean streak was easy to maintain while goodwill was trivial; with the Empira acquisition lifting intangibles and goodwill from $110m to $460m in FY2025, future impairment testing now carries real weight and should be monitored.

Cash-flow quality: strong, but name the mechanism

Do not take FY2025's CFO of $1,911m at face value. It is real cash, but its level is driven by a one-time confluence: a surge of performance-fee realizations collecting into cash, plus the drawdown of the accrued-revenue receivable. Over the full five-year cycle, operating cash conversion has actually lagged net income — CFO/NI averaged 0.83 — precisely because performance fees are booked before they are collected.

Source: FY2025 consolidated cash-flow statement (OCF) and prior-year comparatives; net income from FY2021/FY2025 financial review [3] [2].

CF4 — the FY2025 print is not a run-rate (yellow). The pattern above is the mechanism: in catch-up years (FY2022, FY2025) CFO exceeds net income as accruals collect; in build years (FY2021, FY2023) CFO falls well short. The FY2025 CFO/NI of 1.20 is the collection side of a cycle, not a permanent step-up. Underwriting next year's cash on FY2025's ratio would overstate sustainable conversion.

CF1 — short-term-loan income and movements sit in operating cash flow (yellow). Two presentational choices keep the lending operation inside operating cash flow. First, "compensation from short-term loans" is classified as other operating income and the company explicitly states it "forms part of net cash flow from operating activities" — $114m in FY2024 alone [4] [29]. Second, the change in the short-term-loan balance runs through working capital in operating activities, while the credit facilities that fund the lending sit in financing — where gross churn reached roughly $12.0bn drawn against $11.6bn repaid in FY2025 [20]. This is IFRS-compliant, but it means a slice of operating cash flow is the spread on a leveraged lending book funded in the financing section — a different economic animal from fee cash. Strip it out to see fee-only generation.

Source: FY2025 consolidated statement of financial position — short-term loans and credit facilities drawn (with FY2024 comparatives) [5].

CF2 / CF3 — clean (green). Capex is genuine and minimal in this asset-light model, with no sign of ordinary operating costs capitalized into investing. The Empira and royalty acquisitions are small relative to operating cash flow, and the FY2025 CFO strength is fee collection rather than acquired working capital — no acquisition/disposal cash-flow distortion is evident [3].

Metric hygiene: the EBIT → EBITDA switch

KM1 — the headline-margin change (yellow). Beginning in 2025, Partners Group switched its headline profitability measure from EBIT margin to EBITDA margin in external communication — disclosed both in the FY2024 annual report and the March 2025 results deck [6] [7]. The stated rationale is reasonable — rising M&A activity creates amortization of acquired intangibles that distorts EBIT — but the switch happens to lift the headline margin by roughly 2.5 percentage points just as the EBIT margin is grinding down, from 62.8% (FY2021) to 60.1% (FY2025).

Source: FY2024 and FY2025 annual reports, financial review — EBIT margin 61.3% / EBITDA margin ~63% (FY2024); EBIT margin 60.1% / EBITDA margin 62.8% (FY2025) [28] [1].

A second, softer metric habit reinforces the point: management repeatedly frames the business as running at a "~60% operating margin" target, with the gap to reported margin attributed to growth investments and foreign-exchange movements [8]. This is a mild "we'd be at target if not for investment" framing — worth noting, not alarming. The forensic takeaway: track the EBIT-margin trend, which is slipping, rather than the EBITDA line the company now leads with.

KM2 — balance-sheet framing (yellow). Management describes a "balance-sheet-light" approach, yet the equity ratio has fallen from 60% (FY2021) to 34% (FY2025) while ROE has stayed high [23] [5]. The decline is driven mostly by aggressive capital return — $1,271m of treasury shares and $1,377m of FY2025 dividends — rather than operating leverage, so it is shareholder-friendly rather than distress [20]. But a 34% equity ratio is a materially thinner cushion against the $2.09bn loan book and the contingent earn-out obligations than the 60% of four years earlier, and the firm's net-debt definition nets the short-term loans it has lent out — a presentation that flatters leverage.

Source: FY2021, FY2023, FY2024 and FY2025 annual reports — key figures (equity ratio 60%/51%/42%/34%; ROE 57%/41%/47%/55%) [23] [22] [21] [5].

Breeding ground: concentrated, but with guardrails

The structural conditions are a mixed picture that, on balance, mildly amplifies the accounting risk rather than dampening it — chiefly because the people who set the valuations also control the firm.

• Founder and board concentration (yellow). The three co-founders — Marcel Erni, Alfred Gantner and Urs Wietlisbach — each hold roughly 5% of the shares (about 15% combined), and the board is split four executive (including Executive Chairman Steffen Meister) to four independent directors [12]. Independent directors chair the Risk & Audit and Nomination & Compensation committees, which is a genuine guardrail, but a half-executive board at a firm whose earnings depend on internal marks is a concentration to weigh.
• Incentives tied to performance fees (yellow). A dedicated performance-fee compensation scheme (the management carry plan) allocates a slice of future performance fees to senior staff — $281m pre-allocated in FY2025, up from $141m — so management is directly incentivized on the same performance-fee recognition that drives reported revenue [24]. Payouts are made only once fees are collected, which aligns the plan with cash and is a mitigant.
• Related-party transactions (yellow, low materiality). In July 2024 the firm bought a "royalty business" from an entity controlled by key management personnel for $15.3m in cash, recognizing $17.1m of goodwill and $13.7m of deferred revenue, and asserting arm's-length terms [9] [10]. The sum is small and the disclosure is full, but buying an asset from insiders and immediately booking goodwill on it is a textbook conflict to log.
• Auditor change (neutral-to-watch). PwC replaced long-tenured KPMG as auditor for FY2025, following a competitive tender the Risk & Audit Committee began in 2022; the new lead auditor is subject to a seven-year rotation [11]. This was company-initiated and orderly — not a resignation — so it is a positive reset of a long audit tenure rather than a red flag, though a first-year auditor on a complex valuation-driven book is worth one cycle of extra attention.
• The live overhang (watch). In April 2026 the firm publicly condemned a Grizzly Reports short-seller publication challenging its valuations as "frivolous, defamatory and highly misleading," and through mid-2026 has been managing market concern over evergreen-vehicle redemptions (Q2 redemptions cited around 9.8% of NAV in one vehicle) [27]. These are external, unverified claims the company rejects — but they target the exact pressure point this memo identifies, which is why they raise, rather than resolve, the valuation question.

What to underwrite next

The accounting risk here is a valuation haircut and position-sizing input, not a thesis breaker. Reported profit is largely cash-backed across the cycle and the disclosure is fuller than most. But the model's quality is hostage to internal private-asset marks, and those marks are under live external challenge.

Track these five items into the next interim and annual report:

1. Accrued-revenue receivable behavior. It fell in FY2025 (reporting-currency terms) as exits realized — confirm it keeps converting rather than re-building without collection. A receivable that climbs while cash lags would downgrade the grade [26].
2. Performance-fee clawbacks/reversals. Any reversal of previously recognized performance fees — especially if evergreen NAVs are cut — is the single most diagnostic signal. None to date.
3. Loss allowance on the $2.09bn short-term loan book. Watch for any move off the ~0.1% reserve; a build would confirm the private-credit cycle is biting [14].
4. Empira goodwill ($293m+) impairment testing and the contingent earn-out ($165m) — the first real test of the nil-impairment streak [25].
5. EBIT margin (not EBITDA) and the equity ratio — the two metrics where the company's preferred presentation runs ahead of the underlying trend [1].

Downgrade trigger: a performance-fee clawback, an evergreen NAV markdown, or a loan-book reserve build. Upgrade trigger: another year of CFO ≥ net income with the accrued receivable converting and no clawbacks. Bottom line: the accounting risk at Partners Group is a valuation-confidence and position-sizing limiter — apply a margin of safety to the performance-fee-and-marks portion of earnings and size accordingly — not a footnote, and not, on the current evidence, a thesis breaker.